<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        175-212-02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2002
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        KLAVOX 457MG\5ML SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        400,57
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        70
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        26.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Klavox is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called &ldquo;penicillins&rdquo; that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening. Klavox is used in babies and children to treat the following infections: &bull; Middle ear and sinus infections &bull; Respiratory tract infections &bull; Urinary tract infections &bull; Skin and soft tissue infections including dental infections &bull; Bone and joint infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not give your child Klavox: </strong></p><p><strong>&bull;</strong> If they are allergic (hypersensitive) to amoxicillin, clavulanic acid or any of the other ingredients of Klavox (listed in section 6) &bull; If they have ever had an allergic (hypersensitive) reaction to any other antibiotic. This can include a skin rash or swelling of the face or neck &bull; If they have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic</p><p><strong>Do not give Klavox to your child if any of the above apply to your child.</strong></p><p>&nbsp;</p><p>If you are not sure, talk to your doctor or pharmacist before giving Klavox. Take special care with Klavox Check with your doctor or pharmacist before giving your child this medicine if they: &bull; have glandular fever &bull; are being treated for liver or kidney problems &bull; are not passing water regularly. Abnormal prolongation of prothrombin time (increased INR) has been reported rarely in patients receiving amoxicillin and oral anticoagulants. Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation. If you are not sure if any of the above apply to your child, talk to your doctor or pharmacist before giving Klavox. In some cases, your doctor may investigate the type of bacteria that is causing your child&rsquo;s infection. Depending on the results, your child may be given a different strength of Klavox or a different medicine.</p><p><strong>&nbsp;Conditions you need to look out for</strong></p><p>Klavox can make some existing conditions worse, or cause serious side effects. These include allergic reactions, convulsions (fits) and inflammation of the large intestine. You must look out for certain symptoms while your child is taking Klavox, to reduce the risk of any problems. See <em>&lsquo;Conditions you need to look out for</em>&rsquo; in Section 4.</p><p><strong>Blood or urine tests</strong></p><p>If your child is having blood tests (such as red blood cell status tests or liver function tests) or urine tests, let the doctor or nurse know that they are taking Klavox. This is because Klavox can affect the results of these types of tests.</p><p><strong>Using other medicines </strong></p><p>Please tell your doctor or pharmacist if your child is taking or has recently taken any other medicines. This includes medicines that can be bought without a prescription and herbal medicines.</p><p>● If your child is taking allopurinol (used for gout) with Klavox, it may be more likely that they will have an allergic skin reaction.</p><p>● If your child is taking probenecid (used for gout), your doctor may decide to adjust the dose of Klavox.</p><p>● If medicines to help stop blood clots (such as warfarin) are taken with Klavox then extra blood tests may be needed.</p><p>● In the literature there are rare cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin. If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin (see 2. Before you take Klavox).</p><p>● Klavox can affect how methotrexate (a medicine used to treat cancer or rheumatic diseases) works.</p><p>● Klavox may affect how mycophenolate mofetil (a medicine used to prevent the rejection of transplanted organs) works.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If your patient who is about to take this medicine is pregnant or breast-feeding, please tell your doctor or pharmacist. Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Important information about some of the ingredients of Klavox</strong></p><p>&bull; Klavox does not contain sugar.</p><p>&bull; Klavox contains aspartame (NF) which is a source of phenylalanine. &nbsp;This may be harmful for children born with a condition called &rsquo;phenylketonuria&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always give Klavox exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. To make up to 70ml: first shake bottle to loosen powder. Then add 62ml of water and shake well or add water to 2/3 of fill line level on label, shake well and fill up to the line. Shake well before taking each dose. Adults and children weighing 40 kg or over &bull; This suspension is not usually recommended for adults and children weighing 40 kg and over. Ask your doctor or pharmacist for advice. Children weighing less than 40 kg: All doses are worked out depending on the child&rsquo;s body weight in kilograms. &bull; Your doctor will advise you how much Klavox you should give to your baby or child. &bull; You may be provided with a plastic measuring spoon or plastic measuring cup or dosing syringe. Instructions on how to use the dosing syringe are provided at the end of this leaflet</p><p>. You should use this to give the correct dose to your baby or child.</p><p>&bull; Recommended dose - 25 mg/3.6 mg to 45 mg/6.4 mg for each kilogram of body weight a day, given in two divided doses.</p><p>&bull; Higher dose - up to 70 mg/10 mg for each kilogram of body weight a day, given in two divided doses.&nbsp;</p><p><strong>Patients with kidney and liver problems </strong></p><p><strong>&bull;</strong> If your child has kidney problems the dose might be lowered. A different strength or a different medicine may be chosen by your doctor.</p><p>&bull; If your child has liver problems they may have more frequent blood tests to see how their liver is working.</p><p><strong>How to give Klavox</strong></p><p>&bull; Always shake the bottle well before each dose</p><p>&bull; Give at the start of a meal or slightly before &bull; Space the doses evenly during the day, at least 4 hours apart. Do not take 2 doses in 1 hour</p><p>. &bull; Do not give your child Klavox for more than 2 weeks.</p><p>If your child still feels unwell they should go back to see the doctor.</p><p><strong>If you give more Klavox than you should </strong></p><p>If you give your child too much Klavox, signs might include an upset stomach (feeling sick, being sick or diarrhoea) or convulsions. Talk to their doctor as soon as possible. Take the medicine bottle to show the doctor. If you forget to give Klavox If you forget to give your child a dose, give it as soon as you remember. You should not give your child the next dose too soon, but wait about 4 hours before giving the next dose.</p><p><strong>If your child stops taking Klavo</strong>x</p><p>Keep giving your child Klavox until the treatment is finished, even if he feels better. Your child needs every dose to help fight the infection. If some bacteria survive they can cause the infection to come back. If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Klavox can cause side effects, although not everybody gets them. The side effects below may happen with this medicine. Conditions you need to look out for Allergic reactions:</p><p>&bull; Skin rash</p><p>&bull; Inflammation of blood vessels (vasculitis) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</p><p>&bull; Fever, joint pain, swollen glands in the neck, armpit or groin</p><p>&bull; Swelling, sometimes of the face or mouth (angioedema), causing difficulty in breathing</p><p>&bull; Collapse. Contact a doctor immediately if your child gets any of these symptoms. Stop giving Klavox. Inflammation of large intestine Inflammation of the large intestine, causing watery diarrhoea usually with blood and mucus, stomach pain and/or fever. Contact your doctor as soon as possible for advice if your child gets these symptoms.</p><p><strong>Very common side effects </strong></p><p>These may affect more than 1 in 10 people</p><p>&bull; Diarrhoea (in adults).</p><p><strong>Common side effects</strong></p><p>&bull; These may affect up to 1 in 10 people</p><p>&bull; Thrush (candida - a yeast infection of the vagina, mouth or skin folds)</p><p>&bull; Feeling sick (nausea), especially when taking high doses -</p><p>If affected take Klavox before food</p><p>&bull; Vomiting</p><p>&bull; Diarrhoea (in children).</p><p><strong>Uncommon side effects </strong></p><p>These may affect up to 1 in 100 people</p><p>&bull; Skin rash, itching</p><p>&bull; Raised itchy rash (hives)</p><p>&bull; Indigestion</p><p>&bull; Dizziness</p><p>&bull; Headache.</p><p>Uncommon side effects that may show up in blood tests:</p><p>&bull; Increase in some substances (enzymes) produced by the liver</p><p><strong>Rare side effects These </strong></p><p>may affect up to 1 in 1000 people</p><p>&bull; Skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; erythema multiforme)</p><p>- If you notice any of these symptoms contact a doctor urgently.</p><p>Rare side effects that may show up in blood tests:</p><p>&bull; Low number of cells involved in blood clotting</p><p>&bull; Low number of white blood cells.</p><p>&nbsp;</p><p>Other side effects</p><p>Other side effects have occurred in a very small number of people but their exact frequency is unknown.</p><p>&bull; Allergic reactions</p><p>&bull; Inflammation of the large intestine</p><p>&bull; Prolongation of bleeding time and prothrombin time (see 2. Before you take Klavox)</p><p>&bull; Serious skin reactions:</p><p>- a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form, causing extensive peeling of the skin (more than 30% of the body surface &ndash; toxic epidermal necrolysis)</p><p>- widespread red skin rash with small pus-containing blisters (bullous exfoliative dermatitis)</p><p>- a red, scaly rash with bumps under the skin and blisters (exanthemous pustulosis). Contact a doctor immediately if your child gets any of these symptoms.</p><p>&bull; Inflammation of the liver (hepatitis</p><p>) &bull; Jaundice, caused by increases in the blood of bilirubin (a substance produced in the liver) which may make your child&rsquo;s skin and whites of the eyes appear yellow</p><p>&bull; Inflammation of tubes in the kidney</p><p>&bull; Blood takes longer to clot</p><p>&bull; Hyperactivity</p><p>&bull; Convulsions (in people taking high doses of Klavox or who have kidney problems)</p><p>&bull; Black tongue which looks hairy</p><p>&bull; Stained teeth (in children), usually removed by brushing</p><p>. Side effects that may show up in blood or urine tests:</p><p>&bull; Severe reduction in the number of white blood cells</p><p>&bull; Low number of red blood cells (haemolytic anaemia)</p><p>&bull; Crystals in urine. If your child gets side effects.</p><p>Tell your doctor or pharmacist if any of the side effects become severe or troublesome, or if you notice any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.</p><p>&bull; Do not use Klavox after the expiry date which is stated on the carton. The expiry date refers to the last day of that month</p><p>&bull; The expiry date which is stated on the bottle label is for the pharmacist&rsquo;s use.</p><p>&bull; Once reconstituted the suspension must be stored in a refrigerator and used within 7 days.</p><p>&bull; Store below 25&deg;C</p><p>&bull; Medicines should not be disposed of via wastewater or household waste.</p><p>Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Klavox 457mg/5ml Powder for oral suspension: </strong></p><p>When reconstituted each 5 ml contains 400 mg amoxicillin and 57 mg clavulanic acid. The amoxicillin is present as amoxicillin trihydrate and the clavulanic acid is present as potassium clavulanate.</p><p>&nbsp;</p><p>&bull; The other ingredients are Xantham Gum, Hydroxypropyl Methyl cellulose, Aspartame NF, Colloidal Silicon Dioxide, Succinic Acid, Silicon Dioxide NF 18 Silica Gel, Raspberry Dry Flavour NN07943, Orange Dry Flavour 61027 1 E, Orange Dry Flavour 9/027108, Orange Dry Flavour 653970, Golden Syrup Dry Flavour 52.927.</p><p>&bull; Klavox does not contain sugar.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Klavox 457mg/5ml Powder for oral suspension: 100 ml/pack
Clear bottle with white child-resistant cap
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO</p><p>AlQassim pharmaceutical plant Saudi Pharmaceutical Industries &amp; Medical Appliance Corporation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflets is approved in January 2017. 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>كلافوكس ھو مضاد حیوى و یعمل عن طریق قتل البكتیریا التى تسبب العدوى. وھو یحتوى على دوائین مختلفین ھما أموكسیسیللین و حمض كلافیولانیك. أموكسیسیللین ینتمى لمجموعة من الأدویة تسمى (بینیسیللین) و التى قد تتوقف عن أداء عملھا فى بعض الأوقات (تتحول إلى غیر فاعلة). و المكون الثانى (حمض كلافیولانیك) یمنع حدوث ھذا التوقف. یستخدم كلافوكس للرضع و الأطفال لمعالجة العدوى التالیة :</p><p>&nbsp;</p><p>&nbsp;عدوى الأذن الوسطى والجیوب الأنفیة ●</p><p>عدوى الجھاز التنفسى ●</p><p>عدوى الجھاز البولى ●</p><p>عدوى الجلد و الأغشیة الناعمة بما فى ذلك عدوى الأسنان ●</p><p>عدوى العظام و المفاصل●</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تعطي طفلك كلافوكس :</p><p>● إذا كان لدیھ حساسیة زائدة تجاه أموكسیسیللین أو حمض كلافیولانیك أو أى مكون أخر من مكونات كلافوكس (المذكورة فى الفقرة )6</p><p>● إذا تعرض فى أى وقت من الأوقات إلى تفاعل حساسیة حاد تجاه أى مضاد حیوى آخر. قد یحتوى ذلك على طفح جلدى أو تورم فى الوجھ أو الرقبھ&nbsp;</p><p>● إذا تعرض فى أى وقت من الأوقات إلى مشاكل فى الكبد أو الصفراء (إصفرار الجلد) عند تناول مضاد حیوى</p><p>لا تعطي طفلك كلافوكس إذا كان أى من السابق ذكره ینطبق علیھ. إذا لم تكن متأكد تحدث إلى طبیبك أو الصیدلى قبل تناول كلافوكس.</p><p>ینبغى توخى الحذر مع كلافوكس فى الحالات التالیة</p><p>تحدث إلى طبیبك أو الصیدلى قبل إعطاء طفلك ھذا الدواء فى الحالات التالیة</p><p>● إذا كان لدیھ حمى غدیة</p><p>● إذا كان یتلقى علاج لمشاكل فى الكبد أو الكلى</p><p>● إذا كان لا یتبول بصورة منتظمة</p><p>تم رصد حالات نادرة من إطالة غیر طبیعیة فى وقت البروثرومبین (زیادة INR (فى المرضى الذین یستخدمون أموكسیسیللین و مضادات التجلط. و لذلك ینبغى استخدام وسائل مناسبة للمراقبة عندما یتم وصفھم معا. قد یكون تعدیل جرعة مضاد التجلط ضروریا لمواصلة المستوى المطلوب من مفعول مضاد التجلط. إذا لم تكن متأكد أن أى من السابق ذكره ینطبق علي طفلك تحدث إلى طبیبك أو الصیدلى قبل إعطاء كلافوكس. فى بعض الأحیان قد یتحقق الطبیب بالتحالیل من نوع الباكتیریا المسببھ للعدوى لطفلك. وبناء على النتائج قد یعطى الطبیب لطفلك تركیز مختلف من كلافوكس أو دواء مختلف.</p><p>حالات تحتاج للحذر منھا یمكن لكلافوكس أن یجعل بعض الحالات الموجودة أكثر سوءا, أو یسبب أعراض جانبیة خطیرة. تتضمن ھذه الأعراض تفاعلات حساسیة, التشنجات و التھاب الأمعاء الغلیظة. یجب علیك الحذر من بعض الأعراض خلال تناول طفلك لكلافوكس , للحد من مخاطر أي مشاكل. انظر حالات تحتاج الحذر منھا في قسم .4 تحالیل الدم و البول إذا كان طفلك سوف یقوم بعمل تحلیل للدم (مثل حالة خلایا الدم الحمراء أو وظائف الكبد) أو تحلیل البول. أخبر طبیبك أو الممرضة أنھ یتناول كلافوكس. فقد یؤثر كلافوكس فى نتائج ھذه التحالیل. تناول أدویة أخرى یرجى إخبار الطبیب أو الصیدلي إذا كان طفلك یتناول أو تناول في الآونة الأخیرة أي أدویة أخرى، بما في ذلك الأدویة التي تم الحصول علیھا دون وصفة طبیة.</p><p>● إذا كان یتناول ألوبیورینول (لعلاج النقرص) مع كلافوكس فربما یزید احتمال تعرضھ لتفاعلات حساسیة جلدیة.</p><p>● إذا كان یتناول بروبینسید (لعلاج النقرص) فقد یقرر طبیبك تعدیل جرعة كلافوكس.</p><p>● إذا تناول دواء یساعد على وقف تجلط الدم مثل (وارفارین) مع كلافوكس فربما یحتاج إلى تحالیل دم إضافیة.</p><p>● فى بعض المطبوعات ھناك حالات نادرة من زیادة (INR (فى المرضى الذین یستخدمون اسینوكومارول أو وارفارین مع أموكسیسیللین. لو كان تناولھما معا ضروریا ینبغى مراقبة وقت البروثرومبین أو INR بحرص عند إضافة أو سحب أموكسیسیللین (انظر فقرة 2 .ما یجب مراعاتھ قبل تناول كلافوكس.(</p><p>● قد یؤثر كلافوكس فى طریقة عمل میثوتریكسات (دواء لعلاج السرطان أو الأمراض الروماتیزمیة).</p><p>● قد یؤثر كلافوكس فى طریقة عمل میكوفینولات موفیتیل (وھو دواء یستخدم لمنع رفض الجسم للأعضاء المزروعة).</p><p>الحمل والرضاعة</p><p>فضلا أخبر طبیبك أو الصیدلى إذا كانت المریضة التى سوف تتناول الدواء حامل أو ترضع طفلھا طبیعیا. اسألى طبیبك أو الصیدلى النصیحة قبل تناول أى دواء.</p><p>معلومات مھمة عن بعض من مكونات كلافوكس</p><p>● لا یحتوي كلافوكس على السكر</p><p>● یحتوي كلافوكس على الأسبرتام و ھي مصدر للفینیل الانین. ھذا یمكن أن یضر للأطفال المولودین بحالة تسمى &quot;فینیلكیتونوریا&quot;.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قم دائما بإعطاء كلافوكس تماما كما أخبرك الطبیب المعالج. إذا كنت غیر واثق یجب علیك التحقق من خلال الطبیب أو الصیدلى. ً 62 مل من الماء وقم بھز الزجاجة لتحضیر 70 بھز الزجاجة لإرخاء المسحوق. ثم أضف مل من المسحوق المعلق: قم أولا ً ثم أكمل إضافة الماء إلى ما یصل إلى ً أو أضف الماء إلى جیدا /3 2 من مستوى خط التعبئة الموضح على الملصق, رج جیدا ً قبل إعطاء كل جرعة. خط التعبئة الموضح على الملصق. رج الزجاجة جیدا البالغین و الأطفال (وزن )40 كجم فأكثر</p><p>&nbsp;</p><p>&nbsp;</p><p>● ھذا المعلق لا ینصح بھ عادة للبالغین و الأطفال البالغة أوزانھم 40 كجم أو أكثر . اسأل طبیبك أو الصیدلى للحصول على المشورة</p><p>الأطفال الذین أوزانھم أقل من 40 كجم جمیع الجرعات عملت تبعا لوزن الطفل بالكیلوجرامات</p><p>● طبیبك سوف یرشدك للمقدار الذي یجب أن تعطیھ لطفلك من كلافوكس.</p><p>● یمكن أن تزود بملعقة قیاس بلاستیكیة أو كأس قیاس . أو سرنجة التعلیمات الخاصة بكیفیة استخدام السرنجة لمعایرة الجرعة موضحة فى نھایة النشرة. یجب أن تستخدمھا لإعطاء المقدار الصحیح من الجرعة لطفلك</p><p>● الجرعة الموصى بھا: /25 ملجم ملجم إلى 6.3/ 45 ملجم 4.6 ملجم لكل كیلوجرام من وزن الجسم فى الیوم, تقسم على مرتین</p><p>● الجرعة الأكبر: قد تصل إلى /70 ملجم 10 ملجم لكل كیلوجرام من وزن الجسم فى الیوم, تقسم على مرتین.</p><p>المرضى الذین یعانون من مشاكل في الكلى و الكبد</p><p>● إذا كان یعانى طفلك من مشاكل بالكلى فقد یحتاج إلى تقلیل الجرعة. قد یختار لھ طبیبك تركیز مختلف أو دواء مختلف.</p><p>● إذا كان یعانى طفلك من مشاكل بالكبد فقد یحتاج إلى عمل تحالیل دم بشكل مكثف لتحدید طریقة عمل الكبد.</p><p>كیفیة إعطاء كلافوكس</p><p>● رج العبوة دائما قبل كل جرعة.</p><p>● یعطى في بدایة الوجبة أو قبلھا بقلیل.</p><p>● قسم الجرعات بالتساوي خلال الیوم, على الأقل 4 ساعات عن بعضھا البعض . لا تأخذ جرعتین خلال ساعة واحدة.</p><p>● لا تعطي طفلك كلافوكس لمدة أكثر من أسبوعین . إذا كان طفلك لا یزال بصحة غیر جیدة ینبغي مراجعة الطبیب.</p><p>ذا أعطیت جرعة كلافوكس أكثر مما ینبغى إذا أعطیت طفلك جرعة كبیرة من كلافوكس , قد تظھر علامات تشمل اضطراب في المعدة (الشعود بالغثیان, أو الاسھال) أو التشنجات. تحدث إلى الطبیب في أقرب وقت ممكن, خذ زجاجة الدواء لیراھا الطبیب. إذا نسیت إعطاء كلافوكس إذا نسیت إعطاء طفلك جرعة كلافوكس , قم بإعطاءھا لھ فور تذكرك. لا یجب علیك إعطاء طفلك الجرعة التالیة في وقت قریب, ولكن انتظر لمدة أربع ساعات قبل إعطائھ الجرعة التالیة. إذا توقف طفلك عن تناول كلافوكس داوم على إعطاء طفلك كلافوكس حتى نھایة العلاج حتى لو شعر بتحسن. لأنھ یحتاج كل جرعة للمساعدة فى القضاء على العدوى. لأن بعض البكتیریا قد تسبب عودة العدوى مرة أخرى. إذا كان لدیك أى أسئلة أضافیة عن استخدام ھذا الدواء. اسأل طبیبك أو الصیدلى.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة، كلافوكس قد یسبب أعراض جانبیة، وإن لم تكن تحدث لكل من یتناول ھذا الدواء. ینبغى توخى الحذر من تفاعلات الحساسیة وحالاتھا ھى:</p><p>● طفح جلدى</p><p>● التھاب فى الأوعیة الدمویة و التى تظھر كبقع بلون أحمر أو وردى على الجلد ولكنھا قد تؤثر فى أجزاء أخرى من الجسم</p><p>● حمى أو ألم فى المفاصل أو تورم الغدد فى الرقبة أو الإبط أو الفخذ</p><p>● تورم أحیانا فى الوجة أو الفم مما یسبب صعوبة فى التنفس.</p><p>● تدھور الصحة.</p><p>اتصل بطبیبك فورا إذا لاحظت أى من ھذه الأعراض على طفلك و توقف عن إعطاء كلافوكس. التھاب الأمعاء الغلیظة التھاب الأمعاء الغلیظة مما یسبب إسھال مائى عادة مع دم و مخاط و ألم فى المعدة مع/أو حمى. اتصل بطبیبك فى أقرب وقت للحصول على المشورة إذا كان طفلك تظھر علیھ ھذه الأعراض.</p><p><strong>أعراض جانبیة شائعة جدا</strong></p><p>قد تؤثر فى أكثر من 10 فى كل 1 أشخاص</p><p>● إسھال (فى البالغین)</p><p><strong>أعراض جانبیة شائعة</strong></p><p>قد تؤثر فى حتى 10 فى كل 1 أشخاص</p><p>● مرض القلاع (كاندیدا &ndash; عدوى خمیریة فى المھبل أو الفم أو ثنایا الجلد)</p><p>● الشعور بالإعیاء (غثیان) خصوصا عند تناول جرعات عالیة</p><p>- &nbsp;إذا تناولت كلافوكس قبل الأكل</p><p>● قئ</p><p>● إسھال (فى الأطفال)</p><p><strong>أعراض جانبیة غیر شائعة</strong></p><p>100 فى كل 1تؤثر فى حتى شخص</p><p>● طفح جلدى و حكة</p><p>● طفح وحكة مرتفعة (شرى)</p><p>● سوء ھضم</p><p>● دوار&nbsp;</p><p>● صداع</p><p>عراض جانبیة غیر شائعة والتى قد تظھر فى تحلیل الدم:</p><p>● زیادة فى بعض إنزیمات الكبد. أ</p><p>أعراض جانبیة نادرة</p><p>1000 فى كل 1تؤثر فى حتى شخص</p><p>● طفح جلدى والذى قد یتقشر و یظھر كمستھدفات صغیرة (بقع داكنة مركزیة محاط ببقع أشحب مع حلقة داكنة حول الحافة &ndash; حمامى عدیدة الأشكال)</p><p>- إذا لاحظت أى من ھذه الأعراض اتصل بطبیبك فورا.</p><p>عراض جانبیة نادرة و التى تظھر فى تحلیل الدم:</p><p>● نقص فى عدد خلایا تدخل فى تجلط الدم</p><p>● نقص فى عدد خلایا الدم البیضاء.&nbsp;</p><p>أعراض جانبیة أخرى</p><p>أعراض جانبیة حدثت فى عدد قلیل جدا من الأشخاص ولكن ترددھا غیر معلوم.</p><p>● تفاعلات حساسیة&nbsp;</p><p>● التھاب الأمعاء الغلیظة</p><p>● إطالة وقت النزیف و وقت بروثرومبین (انظر فقرة 2 .ما یجب مراعاتھ قبل تناول كلافوكس(</p><p>● تفاعلات حساسیة حادة:</p><p>- طفح جلدى منتشر مع تقرحات و تقشر و خصوصا حول الفم و الأنف و العین و الأعضاء التناسلیة (متلازمة ستیفینز جونسون) و صورة أكثر حدة تتسبب فى تقشیر واسع فى الجلد (أكثر من 30 %من مساحة الجسم - انحلال البشرة النخري السامة)</p><p>- طفح جلدى أحمر منتشر مع تقرحات تحتوى على صدید (التھاب الجلد الفقاعي التقشري)</p><p>- طفح جلدى أحمر ذو قشور و نتوءات تحت الجلد و تقرحات (بثار طفحى)</p><p>اتصل بطبیبك فورا إذا أصیب طفلك بأى من ھذه الأعراض.</p><p>● التھاب الكبد</p><p>● الصفراء وھى نتیجة لزیادة الصفراء فى الدم (وھى مادة تنتج فى الكبد) و التى تجعل جلدك و بیاض عینیك یبدوان بلون أصفر</p><p>● التھاب فى الكلى</p><p>● یأخد الدم وقت أطول لكى یتجلط</p><p>● فرط نشاط</p><p>● تشنجات (فى المرضى الذین یتناولون جرعات عالیة من كلافوكس أو الذین یعانون من مشاكل فى الكلیة)&nbsp;</p><p>● تلون اللسان باللون الأسود و لذلك یبدو مكسو بالشعر</p><p>● صبغة الأسنان (فى الأطفال) عادة ما تزول بغسیل الأسنان</p><p>أعراض جانبیة قد تظھر فى تحلیل الدم أو البول:</p><p>● نقص حاد فى عدد خلایا الدم البیضاء</p><p>● نقص عدد خلایا الدم الحمراء (فقر الدم الإنحلالي)</p><p>● بلورات فى البول</p><p>إذا تعرض طفلك لأى أعراض جانبیة. فإنھ یرجى أن تخبر طبیبك المعالج أو الصیدلى إذا لاحظت أن أیا من ھذه الأعراض الجانبیة أصبح جسیما، أو إذا لاحظت ظھور أى أعراض جانبیة لم ترد فى ھذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>● یحفظ الدواء بعیدا عن متناول ونظر الأطفال.</p><p>● لا تستعمل كلافوكس بعد انتھاء تاریخ الصلاحیة المدون على العبوة. وتاریخ الإنتھاء یشیر إلى أخر یوم فى الشھر المذكور</p><p>● تاریخ الإنتھاء و المذكور على ملصق العبوة ھو لاستخدام الصیدلى.</p><p>● بمجرد تحضیر المعلق یجب حفظھ فى الثلاجة وینبغى استخدامھ خلال 7 أیام.</p><p>● یحفظ في درجة حرارة أقل من 25 درجة مئویة.</p><p>● یجب عدم التخلص من الأدویة في میاه المجاري أو قمامة المنزل. اسأل الصیدلي كیف تتخلص من الأدویة التي لم تعد بحاجتھا. لأن ھذه الاعتبارات ستعمل على حمایة البیئة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>كلافوكس 5ملجم/ 457 مل مسحوق لعمل معلق فموى: عند إعادة التكوین یحتوى كل 400 مل على 5 ملجم أموكسیسللین و 57 ملجم حمض كلافولانیك. الأموكسیسللین موجود على ھیئة ثلاثى ھیدرات الأموكسیسللین و حمض كلافولانیك على ھیئة كلافولانیك البوتاسیوم.</p><p>&nbsp;</p><p>● المكونات الأخرى ھى صبغ زانثام و ھیدروكسیبروبیل میثیل سیللیلوز و أسبارتام إن إف و ثانى أكسید السیلیكون الغروى و حمض سكسینیك و سیلیكون ثنائى الأكسید إن إف 18 سیلیكا جیل و نكھة التوت البرى الجافة إن إن 07943 و نكھة البرتقال الجافة 610271 إى و نكھة البرتقال الجافة 027108/9 و نكھة البرتقال الجافة 653970 و نكھة الشراب الذھبى الجافة . 52.927</p><p>&nbsp;</p><p>● لا یحتوي كلافوكس على السكر.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كلافوكس /457 ملجم 5مل مسحوق لعمل معلق فموى : 100مل / عبوة عبوة شفافة مع غطاء أبیض مضاد لعبث الأطفال.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الدوائیة مصنع الأدویة بالقصیم الشركة السعودیة للصناعات الدوائیة والمستلزمات الطبیة. المملكة العربیة السعودیة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على ھذه النشرة بتاریخ ینایر .2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Klavox 457mg/5ml.
Powder for Oral Suspension.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Klavox 457mg/5ml Powder for Oral Suspension: When reconstituted each 5 ml
contains 400 mg amoxicillin and 57 mg clavulanic acid.
The amoxicillin is present as amoxicillin trihydrate and the clavulanic acid is present
as potassium clavulanate.
Excipients with known effect:
Contains 2.5 mg of aspartame (NF) per ml.
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for oral suspension. Dry powder for reconstitution in water, at time of
dispensing, to form an oral suspension.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Klavox is indicated for the treatment of the following infections in adults and</p><p>children (see sections 4.2, 4.4 and 5.1):</p><p>&bull; Acute bacterial sinusitis (adequately diagnosed)</p><p>&bull; Acute otitis media</p><p>&bull; Acute exacerbations of chronic bronchitis (adequately diagnosed)</p><p>&bull; Community acquired pneumonia</p><p>&bull; Cystitis</p><p>&bull; Pyelonephritis</p><p>&bull; Skin and soft tissue infections in particular cellulitis, animal bites, severe dental</p><p>abscess with spreading cellulitis.</p><p>&bull; Bone and joint infections, in particular osteomyelitis.</p><p>Consideration should be given to official guidance on the appropriate use of</p><p>antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except</p><p>when doses are stated in terms of an individual component.</p><p>To make up to 70ml: first shake bottle to loosen powder. Then add 62ml of water and</p><p>shake well or add water to 2/3 of fill line level on label, shake well and fill up to the line.</p><p>Shake well before taking each dose.</p><p>The dose of Klavox that is selected to treat an individual infection should take into&nbsp;account:</p><p>&bull; The expected pathogens and their likely susceptibility to antibacterial agents (see</p><p>section 4.4)</p><p>&bull; The severity and the site of the infection</p><p>&bull; The age, weight and renal function of the patient as shown below.</p><p>The use of alternative presentations of Klavox (e.g. those that provide higher doses of</p><p>amoxicillin and/or different ratios of amoxicillin to clavulanic acid) should be considered</p><p>as necessary (see sections 4.4 and 5.1).</p><p>For children &lt; 40 kg, this formulation of Klavox provides a maximum daily dose of</p><p>1000-2800 mg amoxicillin/143-400 mg clavulanic acid, when administered as</p><p>recommended below. If it is considered that a higher daily dose of amoxicillin is</p><p>required, it is recommended that another preparation of Klavox is selected in order to</p><p>avoid administration of unnecessarily high daily doses of clavulanic acid (see sections 4.4&nbsp;and 5.1).</p><p>The duration of therapy should be determined by the response of the patient. Some</p><p>infections (e.g. osteomyelitis) require longer periods of treatment. Treatment should not&nbsp;be extended beyond 14 days without review (see section 4.4 regarding prolonged&nbsp;therapy).</p><p><u>Children</u> &ge; 40 kg should be treated with the adult formulations of Klavox.</p><p><u>Children</u> &lt; 40 kg</p><p>Children may be treated with Klavox tablets, suspensions or paediatric sachets.</p><p>Recommended doses:</p><p>&bull; 25 mg/3.6 mg/kg/day to 45 mg/6.4 mg/kg/day given as two divided doses;</p><p>&bull; up to 70 mg/10 mg/kg/day given as two divided doses may be considered for some</p><p>infections (such as otitis media, sinusitis and lower respiratory tract infections).</p><p>No clinical data are available for Klavox 7:1 formulations regarding doses higher than 45&nbsp;mg/6.4 mg per kg per day in children under 2 years</p><p>There are no clinical data for Klavox 7:1 formulations for patients under 2 months of age.</p><p>Dosing recommendations in this population therefore cannot be made.</p><p><u>Elderly</u></p><p>No dose adjustment is considered necessary.</p><p><u>Renal impairment</u></p><p>No dose adjustment is required in patients with creatinine clearance (CrCl) greater than&nbsp;30 ml/min.</p><p>In patients with creatinine clearance less than 30 ml/min, the use of Klavox presentations&nbsp;with an amoxicillin to clavulanic acid ratio of 7:1 is not recommended, as no</p><p>recommendations for dose adjustments are available.</p><p><u>Hepatic impairment</u></p><p>Dose with caution and monitor hepatic function at regular intervals (see sections 4.3 and&nbsp;4.4).</p><p><u>Method of administration</u></p><p>Klavox is for oral use.</p><p>Administer at the start of a meal to minimise potential gastrointestinal intolerance and</p><p>optimise absorption of amoxicillin/clavulanic acid.</p><p>Therapy can be started parenterally according to the SmPC of the IV-formulation and&nbsp;continued with an oral preparation.</p><p>Shake to loosen powder, add water as directed, invert and shake.&nbsp;</p><p>Shake the bottle before each dose (see section 6.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances, to any of the penicillins or to any of the
excipients.
History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another
beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see
section 4.8).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be</p><p>made concerning previous hypersensitivity reactions to penicillins, cephalosporins or</p><p>other beta-lactam agents (see sections 4.3 and 4.8).</p><p>Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been</p><p>reported in patients on penicillin therapy. These reactions are more likely to occur in</p><p>individuals with a history of penicillin hypersensitivity and in atopic individuals. If an</p><p>allergic reaction occurs, amoxicillin/clavulanic acid therapy must be discontinued and&nbsp;</p><p>appropriate alternative therapy instituted.</p><p>In the case that an infection is proven to be due to an amoxicillin-susceptible</p><p>organisms(s) then consideration should be given to switching from</p><p>amoxicillin/clavulanic acid to amoxicillin in accordance with official guidance.</p><p>This presentation of Klavox is not suitable for use when there is a high risk that the</p><p>presumptive pathogens have reduced susceptibility or resistance to beta-lactam agents</p><p>that is not mediated by beta-lactamases susceptible to inhibition by clavulanic acid.</p><p>This presentation should not be used to treat penicillin-resistant S. pneumoniae.</p><p>Convulsions may occur in patients with impaired renal function or in those receiving</p><p>high doses (see section 4.8).</p><p>Amoxicillin/clavulanic acid should be avoided if infectious mononucleosis is&nbsp;suspected since the occurrence of a morbilliform rash has been associated with this&nbsp;condition following the use of amoxicillin.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the&nbsp;likelihood of allergic skin reactions.</p><p>Prolonged use may occasionally result in overgrowth of non-susceptible organisms.</p><p>The occurrence at the treatment initiation of a feverish generalised erythema&nbsp;associated with pustula may be a symptom of acute generalised exanthemous</p><p>pustulosis (AGEP) (see Section 4.8). This reaction requires Klavox discontinuation&nbsp;and contra-indicates any subsequent administration of amoxicillin.</p><p>Amoxicillin/clavulanic acid should be used with caution in patients with evidence of&nbsp;hepatic impairment (see section 4.2, 4.3 and 4.8).</p><p>Hepatic events have been reported predominantly in males and elderly patients and</p><p>may be associated with prolonged treatment. These events have been very rarely&nbsp;reported in children. In all populations, signs and symptoms usually occur during or</p><p>shortly after treatment but in some cases may not become apparent until several</p><p>weeks after treatment has ceased. These are usually reversible. Hepatic events may be&nbsp;severe and, in extremely rare circumstances, deaths have been reported. These have&nbsp;almost always occurred in patients with serious underlying disease or taking&nbsp;concomitant medications known to have the potential for hepatic effects (see section4.8).</p><p>Antibiotic-associated colitis has been reported with nearly all antibacterial agents and&nbsp;may range in severity from mild to life threatening (see section 4.8). Therefore, it is&nbsp;important to consider this diagnosis in patients who present with diarrhoea during or&nbsp;subsequent to the administration of any antibiotics. Should antibiotic-associated&nbsp;colitis occur, amoxicillin/clavulanic acid should immediately be discontinued, a</p><p>physician be consulted and an appropriate therapy initiated. Anti-peristaltic medicinal&nbsp;products are contra-indicated in this situation.</p><p>Periodic assessment of organ system functions, including renal, hepatic and&nbsp;haematopoietic function is advisable during prolonged therapy.</p><p>Abnormal prolongation of prothrombin time (increased INR) has been reported rarely&nbsp;in patients receiving amoxicillin and oral anticoagulants. Appropriate monitoring&nbsp;should be undertaken when anticoagulants are prescribed concurrently. Adjustments</p><p>in the dose of oral anticoagulants may be necessary to maintain the desired level of&nbsp;anticoagulation (see section 4.5 and 4.8).</p><p>In patients with renal impairment, the dose should be adjusted according to the degree&nbsp;of impairment (see section 4.2).</p><p>In patients with reduced urine output, crystalluria has been observed very rarely,</p><p>predominantly with parenteral therapy. During the administration of high doses of&nbsp;amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in</p><p>order to reduce the possibility of amoxicillin crystalluria. In patients with bladder&nbsp;catheters, a regular check of patency should be maintained (see section 4.9).</p><p>During treatment with amoxicillin, enzymatic glucose oxidase methods should be&nbsp;used whenever testing for the presence of glucose in urine because false positive&nbsp;results may occur with non-enzymatic methods.</p><p>The presence of Clavulanic acid in Klavox may cause a non-specific binding of IgG&nbsp;and albumin by red cell membranes leading to a false positive Coombs test.</p><p>There have been reports of positive test results using the Bio-Rad Laboratories</p><p>Platelia Aspergillus EIA test in patients receiving amoxicillin/clavulanic acid who</p><p>were subsequently found to be free of Aspergillus infection. Cross-reactions with&nbsp;non-Aspergillus polysaccharides and polyfuranoses with Bio-Rad Laboratories&nbsp;</p><p>Platelia Aspergillus EIA test have been reported. Therefore, positive test results in</p><p>patients receiving amoxicillin/clavulanic acid should be interpreted cautiously and&nbsp;confirmed by other diagnostic methods.</p><p>Klavox powder for oral suspension contains 2.5 mg of aspartame (NF) per ml, a&nbsp;source of phenylalanine. This medicine should be used with caution in patients with&nbsp;phenylketonuria.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Oral anticoagulants</u></p><p>Oral anticoagulants and penicillin antibiotics have been widely used in practice&nbsp;without reports of interaction. However, in the literature there are cases of increased&nbsp;international normalised ratio in patients maintained on acenocoumarol or warfarin&nbsp;and prescribed a course of amoxicillin. If co-administration is necessary, the</p><p>prothrombin time or international normalised ratio should be carefully monitored&nbsp;with the addition or withdrawal of amoxicillin. Moreover, adjustments in the dose of&nbsp;oral anticoagulants may be necessary (see sections 4.4 and 4.8).</p><p><u>Methotrexate</u></p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in&nbsp;toxicity.</p><p><u>Probenecid</u></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal&nbsp;tubular secretion of amoxicillin. Concomitant use of probenecid may result in&nbsp;increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p><u>Mycophenolate mofetil</u></p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of&nbsp;the active metabolite mycophenolic acid (MPA) of approximately 50% has been&nbsp;reported following commencement of oral amoxicillin plus clavulanic acid. The&nbsp;change in pre-dose level may not accurately represent changes in overall MPA&nbsp;exposure. Therefore, a change in the dose of mycophenolate mofetil should not&nbsp;normally be necessary in the absence of clinical evidence of graft dysfunction.&nbsp;However, close clinical monitoring should be performed during the combination and&nbsp;shortly after antibiotic treatment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Pregnancy category: B.</p><p>Animal studies do not indicate direct or indirect harmful effects with respect to</p><p>pregnancy, embryonal/foetal development, parturition or postnatal development (see</p><p>section 5.3). Limited data on the use of amoxicillin/clavulanic acid during pregnancy</p><p>in humans do not indicate an increased risk of congenital malformations. In a single</p><p>study in women with preterm, premature rupture of the foetal membrane it was</p><p>reported that prophylactic treatment with amoxicillin/clavulanic acid may be</p><p>associated with an increased risk of necrotising enterocolitis in neonates. Use should</p><p>be avoided during pregnancy, unless considered essential by the physician.</p><p><u>Lactation</u></p><p>Both substances are excreted into breast milk (nothing is known of the effects of</p><p>clavulanic acid on the breast-fed infant). Consequently, diarrhoea and fungus</p><p>infection of the mucous membranes are possible in the breast-fed infant, so that</p><p>breast-feeding might have to be discontinued. Amoxicillin/clavulanic acid should</p><p>only be used during breast-feeding after benefit/risk assessment by the physician in</p><p>charge.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been&nbsp;performed. However, undesirable effects may occur (e.g. allergic reactions, dizziness,&nbsp;convulsions), which may influence the ability to drive and use machines (see section&nbsp;4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea</p><p>and vomiting.</p><p>The ADRs derived from clinical studies and post-marketing surveillance with Klavox,</p><p>sorted by MedDRA System Organ Class are listed below.</p><p>The following terminologies have been used in order to classify the occurrence of</p><p>undesirable effects.</p><p>Very common (&ge;1/10)</p><p>Common (&ge;1/100 to &lt;1/10)</p><p>Uncommon (&ge;1/1,000 to &lt;1/100)</p><p>Rare (&ge;1/10,000 to &lt;1/1,000)</p><p>Very rare (&lt;1/10,000)</p><p>Not known (cannot be estimated from the available data)</p><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:250px"><p><u><strong>Infections and infestations</strong></u></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Mucocutaneous candidosis</p></td><td style="width:248px"><p>Common</p></td></tr><tr><td style="width:250px"><p>Overgrowth of non-susceptible&nbsp;organisms</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Blood and lymphatic system&nbsp;disorders</p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Reversible leucopenia</p><p>(including neutropenia)</p></td><td style="width:248px"><p>Rare</p></td></tr><tr><td style="width:250px"><p>Thrombocytopenia</p></td><td style="width:248px"><p>Rare</p></td></tr><tr><td style="width:250px"><p>Reversible agranulocytosis</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Haemolytic anaemia</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Prolongation of bleeding time</p><p>and prothrombin time<sup>1</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p><u><strong>Immune system disorders<sup>10</sup></strong></u></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Angioneurotic oedema</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Anaphylaxis</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Serum sickness-like syndrome</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Hypersensitivity vasculitis</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p><u><strong>Nervous system disorders</strong></u></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Dizziness</p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Headache</p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Reversible hyperactivity</p></td><td style="width:248px">Not known</td></tr><tr><td style="width:250px"><p>Convulsions<sup>2</sup></p></td><td style="width:248px">Not known</td></tr><tr><td style="width:250px"><p><u><strong>Gastrointestinal disorders</strong></u></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Diarrhoea</p></td><td style="width:248px"><p>Common</p></td></tr><tr><td style="width:250px"><p>Nausea<sup>3</sup></p></td><td style="width:248px"><p>Common</p></td></tr><tr><td style="width:250px"><p>Vomiting</p></td><td style="width:248px"><p>Common</p></td></tr><tr><td style="width:250px"><p>Indigestion</p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Antibiotic-associated colitis<sup>4</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Black hairy tongue</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Tooth discolouration<sup>11</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p><strong><u>Hepatobiliary disorders</u></strong></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Rises in AST and/or ALT<sup>5</sup></p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Hepatitis<sup>6</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Cholestatic jaundice<sup>6</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p><u><strong>Skin and subcutaneous tissue</strong></u></p><p><u><strong>disorders</strong></u><sup> 7</sup></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Skin rash</p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Pruritus</p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Urticaria</p></td><td style="width:248px"><p>Uncommon</p></td></tr><tr><td style="width:250px"><p>Erythema multiforme</p></td><td style="width:248px"><p>Rare</p></td></tr><tr><td style="width:250px"><p>Stevens-Johnson syndrome</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Toxic epidermal necrolysis</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Bullous exfoliative-dermatitis</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Acute generalised exanthemous</p><p>pustulosis (AGEP)<sup>9</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p><strong><u>Renal and urinary disorders</u></strong></p></td><td style="width:248px">&nbsp;</td></tr><tr><td style="width:250px"><p>Interstitial nephritis</p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td style="width:250px"><p>Crystalluria<sup>8</sup></p></td><td style="width:248px"><p>Not known</p></td></tr><tr><td colspan="2" style="width:250px"><p><sup>1</sup> See section 4.4</p><p><sup>2</sup> See section 4.4</p><p><sup>3 </sup>Nausea is more often associated with higher oral doses. If gastrointestinal</p><p>reactions are evident, they may be reduced by taking Klavox at the start of a meal.</p><p><sup>4</sup> Including pseudomembranous colitis and haemorrhagic colitis (see section 4.4)</p><p><sup>5</sup> A moderate rise in AST and/or ALT has been noted in patients treated with betalactam</p><p>class antibiotics, but the significance of these findings is unknown.</p><p><sup>6 </sup>These events have been noted with other penicillins and cephalosporins (see</p><p>section 4.4).</p><p><sup>7 </sup>If any hypersensitivity dermatitis reaction occurs, treatment should be</p><p>discontinued (see section 4.4).</p><p><sup>8 </sup>See section 4.9</p><p><sup>9</sup> See section 4.4</p><p><sup>10</sup> See sections 4.3 and 4.4</p><p><sup>11 </sup>Superficial tooth discolouration has been reported very rarely in children. Good</p><p>oral hygiene may help to prevent tooth discolouration as it can usually be removed</p><p>by brushing.</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>To report any side effect(s):</p><p> The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms and signs of overdose</u></p><p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may</p><p>be evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been</p><p>observed (see section 4.4).</p><p>Convulsions may occur in patients with impaired renal function or in those receiving</p><p>high doses.</p><p>Amoxicillin has been reported to precipitate in bladder catheters, predominantly after</p><p>intravenous administration of large doses. A regular check of patency should be</p><p>maintained (see section 4.4).</p><p><u>Treatment of intoxication</u></p><p>Gastrointestinal symptoms may be treated symptomatically, with attention to the</p><p>water/electrolyte balance.</p><p>Amoxicillin/clavulanic acid can be removed from the circulation by <u>haemodialysis</u>.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase</p><p>inhibitors; ATC code: J01CR02.</p><p><u>Mode of action</u></p><p>Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or</p><p>more enzymes (often referred to as penicillin-binding proteins, PBPs) in the</p><p>biosynthetic pathway of bacterial peptidoglycan, which is an integral structural</p><p>component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to</p><p>weakening of the cell wall, which is usually followed by cell lysis and death.</p><p>Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant</p><p>bacteria and therefore the spectrum of activity of amoxicillin alone does not include</p><p>organisms which produce these enzymes.</p><p>Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some</p><p>beta-lactamase enzymes thereby preventing inactivation of amoxicillin. Clavulanic</p><p>acid alone does not exert a clinically useful antibacterial effect.</p><p><u>PK/PD relationship</u></p><p>The time above the minimum inhibitory concentration (T&gt;MIC) is considered to be</p><p>the major determinant of efficacy for amoxicillin.</p><p><u>Mechanisms of resistance</u></p><p>The two main mechanisms of resistance to amoxicillin/clavulanic acid are:</p><p>&bull; Inactivation by those bacterial beta-lactamases that are not themselves inhibited by</p><p>clavulanic acid, including class B, C and D.</p><p>&bull; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.</p><p>Impermeability of bacteria or efflux pump mechanisms may cause or contribute to</p><p>bacterial resistance, particularly in Gram-negative bacteria.</p><p><u>Breakpoints</u></p><p>MIC breakpoints for amoxicillin/clavulanic acid are those of the European Committee</p><p>on Antimicrobial Susceptibility Testing (EUCAST)</p><table border="1" cellspacing="1" cellpadding="1" style="width:638px"><tbody><tr><td style="width:286px"><p>Organism</p></td><td style="width:60px"><p>Susceptibility</p><p>Breakpoints</p><p>(&mu;g/ml)</p></td><td style="width:128px">&nbsp;</td><td style="width:132px">&nbsp;</td></tr><tr><td style="width:286px">&nbsp;</td><td style="width:60px"><p>Susceptible</p></td><td style="width:128px">Intermediate</td><td style="width:132px">Resistant</td></tr><tr><td style="width:286px"><p>Haemophilus&nbsp;influenzae<sup>1</sup></p></td><td style="width:60px"><p>&le; 1</p></td><td style="width:128px"><p>-</p></td><td style="width:132px"><p>&gt; 1</p></td></tr><tr><td style="width:286px"><p>Moraxella catarrhalis<sup>1</sup></p></td><td style="width:60px"><p>&le; 1</p></td><td style="width:128px"><p>-</p></td><td style="width:132px"><p>&gt; 1</p></td></tr><tr><td style="width:286px"><p>Staphylococcus aureus&nbsp;<sup>2</sup></p></td><td style="width:60px"><p>&le; 2</p></td><td style="width:128px"><p>-</p></td><td style="width:132px"><p>&gt; 2</p></td></tr><tr><td style="width:286px"><p>Coagulase-negative&nbsp;staphylococci<sup> 2</sup></p></td><td style="width:60px"><p>&le; 0.25</p></td><td style="width:128px">&nbsp;</td><td style="width:132px"><p>&gt; 0.25</p></td></tr><tr><td style="width:286px"><p>Enterococcus<sup>1</sup></p></td><td style="width:60px"><p>&le; 4</p></td><td style="width:128px"><p>8</p></td><td style="width:132px"><p>&gt; 8</p></td></tr><tr><td style="width:286px"><p>Streptococcus A, B, C,&nbsp;G<sup>5</sup></p></td><td style="width:60px"><p>&le; 0.25</p></td><td style="width:128px"><p>-</p></td><td style="width:132px"><p>&gt; 0.25</p></td></tr><tr><td style="width:286px"><p>Streptococcus&nbsp;pneumoniae<sup>3</sup></p></td><td style="width:60px"><p>&le; 0.5</p></td><td style="width:128px"><p>1-2</p></td><td style="width:132px"><p>&gt; 2</p></td></tr><tr><td style="width:286px"><p>Enterobacteriaceae<sup>1,4</sup></p></td><td style="width:60px"><p>-</p></td><td style="width:128px"><p>-</p></td><td style="width:132px"><p>&gt; 8</p></td></tr><tr><td style="width:286px"><p>Gram-negative&nbsp;Anaerobes<sup>1</sup></p></td><td style="width:60px"><p>&le; 4</p></td><td style="width:128px"><p>8</p></td><td style="width:132px"><p>&gt; 8</p></td></tr><tr><td style="width:286px"><p>Gram-positive&nbsp;Anaerobes<sup>1</sup></p></td><td style="width:60px"><p>&le; 4</p></td><td style="width:128px"><p>8</p></td><td style="width:132px"><p>&gt; 8</p></td></tr><tr><td style="width:286px"><p>Non-species related&nbsp;breakpoints<sup>1</sup></p></td><td style="width:60px"><p>&le; 2</p></td><td style="width:128px"><p>4-8</p></td><td style="width:132px"><p>&gt; 8</p></td></tr><tr><td colspan="4" style="width:635px"><p><sup>1 </sup>The reported values are for Amoxicillin&nbsp;concentrations. For susceptibility testing&nbsp;purposes, the concentration of&nbsp;Clavulanic acid is fixed at 2 mg/l.</p><p><sup>2</sup> The reported values are Oxacillin&nbsp;concentrations.</p><p><sup>3</sup> Breakpoint values in the table are based&nbsp;on Ampicillin breakpoints.</p><p><sup>4</sup> The resistant breakpoint of R&gt;8 mg/l&nbsp;ensures that all isolates with resistance&nbsp;mechanisms are reported resistant.</p><p><sup>5</sup> Breakpoint values in the table are based&nbsp;on Benzylpenicillin breakpoints.</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected</p><p>species, and local information on resistance is desirable, particularly when treating</p><p>severe infections. As necessary, expert advice should be sought when the local</p><p>prevalence of resistance is such that the utility of the agent in at least some types of</p><p>infections is questionable.</p><table border="1" cellspacing="1" cellpadding="1" style="width:731px"><tbody><tr><td style="width:728px"><p>Commonly susceptible species</p></td></tr><tr><td style="width:728px"><p><u>Aerobic Gram-positive micro-organisms</u></p><p>Enterococcus faecalis</p><p>Gardnerella vaginalis</p><p>Staphylococcus aureus ( methicillin-susceptible)&pound;</p><p>Coagulase-negative staphylococci (methicillin-susceptible)</p><p>Streptococcus agalactiae</p><p>Streptococcus pneumoniae<sup>1</sup></p><p>Streptococcus pyogenes and other beta-haemolytic streptococci</p><p>Streptococcus viridans group</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p>Capnocytophaga spp.</p><p>Eikenella corrodens</p><p>Haemophilus influenzae<sup>2</sup></p><p>Moraxella catarrhalis</p><p>Pasteurella multocida</p><p><u>Anaerobic micro-organisms</u></p><p>Bacteroides fragilis</p><p>Fusobacterium nucleatum</p><p>Prevotella spp.</p></td></tr><tr><td style="width:728px"><p><u>Species for which acquired resistance may be a problem</u></p></td></tr><tr><td style="width:728px"><p><u>Aerobic Gram-positive micro-organisms</u></p><p>Enterococcus faecium $</p><p><u>Aerobic Gram-negative micro-organisms</u></p><p>Escherichia coli</p><p>Klebsiella oxytoca</p><p>Klebsiella pneumoniae</p><p>Proteus mirabilis</p><p>Proteus vulgaris</p></td></tr><tr><td style="width:728px"><p><u>Inherently resistant organisms</u></p></td></tr><tr><td style="width:728px"><p><u>Aerobic Gram-negative micro-organisms</u></p><p>Acinetobacter sp.</p><p>Citrobacter freundii</p><p>Enterobacter sp.</p><p>Legionella pneumophila</p><p>Morganella morganii</p><p>Providencia spp.</p><p>Pseudomonas sp.</p><p>Serratia sp.</p><p>Stenotrophomonas maltophilia</p><p><u>Other micro-organisms</u></p><p>Chlamydophila pneumoniae</p><p>Chlamydophila psittaci</p><p>Coxiella burnetti</p><p>Mycoplasma pneumoniae</p></td></tr><tr><td style="width:728px"><p>$ Natural intermediate susceptibility in the absence of acquired mechanism of&nbsp;resistance.</p><p>&pound; All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid</p><p><sup>1</sup>Streptococcus pneumoniae that are resistant to penicillin should not be treated with&nbsp;this presentation of amoxicillin/clavulanic acid (see sections 4.2 and 4.4).</p><p><sup>2</sup> Strains with decreased susceptibility have been reported in some countries in the&nbsp;EU with a frequency higher than 10%.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Amoxicillin and clavulanic acid, are fully dissociated in aqueous solution at physiological pH.</p><p>Both components are rapidly and well absorbed by the oral route of administration. Absorptionof amoxicillin/clavulanic acid is optimised when taken at the start of a meal. Following oraladministration, amoxicillin and clavulanic acid are approximately 70% bioavailable. The plasmaprofiles of both components are similar and the time to peak plasma concentration (Tmax) in each</p><p>case is approximately one hour.The pharmacokinetic results for a study, in which amoxicillin/clavulanic acid (875 mg/125 mg</p><p>tablets given twice daily) was administered in the fasting state to groups of healthy volunteersare presented below.</p><table border="1" cellspacing="1" cellpadding="1" style="width:732px"><tbody><tr><td colspan="6" style="width:729px"><p>Mean (&plusmn; SD) pharmacokinetic parameters</p></td></tr><tr><td style="width:220px"><p>Active substance(s)&nbsp;administered</p><p>&nbsp;</p></td><td style="width:91px"><p>Dose&nbsp;(mg)</p></td><td style="width:101px"><p>Cmax&nbsp;(&mu;g/ml)</p></td><td style="width:112px"><p>Tmax <sup>*</sup>&nbsp;(h)</p></td><td style="width:109px"><p>AUC (0-24h)</p><p>((&mu;g.h/ml)</p></td><td style="width:95px"><p>T&nbsp;1/2&nbsp;(h)</p></td></tr><tr><td style="width:220px"><p>Amoxicillin</p><p>AMX/CA</p><p>875 mg/125 mg</p><p>&nbsp;</p></td><td style="width:91px"><p>875</p></td><td style="width:101px"><p>11.64</p><p>&plusmn; 2.78</p></td><td style="width:112px"><p>1.50</p><p>(1.0-2.5)</p></td><td style="width:109px"><p>53.52</p><p>&plusmn; 12.31</p></td><td style="width:95px"><p>1.19</p><p>&plusmn; 0.21</p></td></tr><tr><td style="width:220px"><p>Clavulanic acid</p><p>AMX/CA</p><p>875 mg/125 mg</p></td><td style="width:91px"><p>125</p></td><td style="width:101px"><p>2.18</p><p>&plusmn; 0.99</p></td><td style="width:112px"><p>1.25</p><p>(1.0-2.0)</p></td><td style="width:109px"><p>10.16</p><p>&plusmn; 3.04</p></td><td style="width:95px"><p>0.96</p><p>&plusmn; 0.12</p></td></tr><tr><td colspan="6" style="width:729px"><p>AMX &ndash; amoxicillin, CA &ndash; clavulanic acid</p><p>* Median (range)</p></td></tr></tbody></table><p>&nbsp;</p><p>Amoxicillin and clavulanic acid serum concentrations achieved with amoxicillin/clavulanic</p><p>acid are similar to those produced by the oral administration of equivalent doses of amoxicillin</p><p>or clavulanic acid alone.</p><p><u>Distribution</u></p><p>About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to</p><p>protein. The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around</p><p>0.2 l/kg for clavulanic acid.</p><p>Following intravenous administration, both amoxicillin and clavulanic acid have been found in</p><p>gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile and</p><p>pus. Amoxicillin does not adequately distribute into the cerebrospinal fluid.</p><p>From animal studies there is no evidence for significant tissue retention of drug-derived material</p><p>for either component. Amoxicillin, like most penicillins, can be detected in breast milk. Trace</p><p>quantities of clavulanic acid can also be detected in breast milk (see section 4.6).</p><p>Both amoxicillin and clavulanic acid have been shown to cross the placental barrier (see section4.6).</p><p><u>Biotransformation</u></p><p>Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent</p><p>to up to 10 to 25% of the initial dose. Clavulanic acid is extensively metabolized in man and</p><p>eliminated in urine and faeces and as carbon dioxide in expired air.</p><p><u>Elimination</u></p><p>The major route of elimination for amoxicillin is via the kidney, whereas for clavulanic acid it is</p><p>by both renal and non-renal mechanisms.</p><p>Amoxicillin/clavulanic acid has a mean elimination half-life of approximately one hour and a</p><p>mean total clearance of approximately 25 l/h in healthy subjects. Approximately 60 to 70% of</p><p>the amoxicillin and approximately 40 to 65% of the clavulanic acid are excreted unchanged in</p><p>urine during the first 6 h after administration of single Klavox 250 mg/125 mg or 500 mg/125</p><p>mg tablets. Various studies have found the urinary excretion to be 50-85% for amoxicillin and</p><p>between 27-60% for clavulanic acid over a 24 hour period. In the case of clavulanic acid, the</p><p>largest amount of drug is excreted during the first 2 hours after administration.</p><p>Concomitant use of probenecid delays amoxicillin excretion but does not delay renal excretion</p><p>of clavulanic acid (see section 4.5).</p><p><u>Age</u></p><p>The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years&nbsp;and older children and adults. For very young children (including preterm newborns) in the first&nbsp;week of life the interval of administration should not exceed twice daily administration due to&nbsp;immaturity of the renal pathway of elimination. Because elderly patients are more likely to have&nbsp;decreased renal function, care should be taken in dose selection, and it may be useful to monitor&nbsp;renal function.</p><p><u>Gender</u></p><p>Following oral administration of amoxicillin/clavulanic acid to healthy males and female</p><p>subjects, gender has no significant impact on the pharmacokinetics of either amoxicillin or</p><p>clavulanic acid.</p><p><u>Renal impairment</u></p><p>The total serum clearance of amoxicillin/clavulanic acid decreases proportionately with</p><p>decreasing renal function. The reduction in drug clearance is more pronounced for amoxicillin</p><p>than for clavulanic acid, as a higher proportion of amoxicillin is excreted via the renal route.</p><p>Doses in renal impairment must therefore prevent undue accumulation of amoxicillin while</p><p>maintaining adequate levels of clavulanic acid (see section 4.2).</p><p><u>Hepatic impairment</u></p><p>Hepatically impaired patients should be dosed with caution and hepatic function monitored at</p><p>regular intervals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nonclinical data reveal no special hazard for humans based on studies of safety</p><p>pharmacology, genotoxicity and toxicity to reproduction.</p><p>Repeat dose toxicity studies performed in dogs with amoxicillin/clavulanic acid</p><p>demonstrate gastric irritancy and vomiting, and discoloured tongue.</p><p>Carcinogenicity studies have not been conducted with Klavox or its components.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Klavox Powder for Oral Suspension excipients</p><p>● Xantham Gum</p><p>● Hydroxypropyl Methyl cellulose</p><p>● Aspartame NF</p><p>● Colloidal Silicon Dioxide</p><p>● Succinic Acid</p><p>● Silicon Dioxide NF 18 Silica Gel</p><p>● Raspberry Dry Flavour NN07943</p><p>● Orange Dry Flavour 61027 1 E</p><p>● Orange Dry Flavour 9/027108</p><p>● Orange Dry Flavour 653970</p><p>● Golden Syrup Dry Flavour 52.927</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
• Once reconstituted the suspension must be stored in a refrigerator and used
within 7 days.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Klavox 457mg/5ml Powder for Oral Suspension: 100 ml/pack</p><p>Clear bottle with white child-resistant cap.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special disposal</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                January 2017.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>